Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT03987074 · COMPLETED
Trial details
- NCT number
- NCT03987074
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-29
- Primary completion
- 2020-07-13
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.